SAI MedPartners competitors

Remco specializes in helping life-sciences organizations develop global go-to-market and product lifecycle maximization strategies, addressing critical external stakeholder groups and leveraging internal functional expertise. He also serves as Putnam’s Boston Office Head. Since joining Putnam in 2000, Remco has served clients in the pharmaceutical, biotech and medical device industries on projects focused in both domestic and international markets. His therapeutic area experience includes Vaccines, Oncology, CNS, Immunology, Infectious Disease, and Women’s Health. Remco’s most recent area of focus has been assisting organizations in defining the potential value of new compounds, making informed portfolio prioritization decisions, and formulating clinical development and commercialization plans that maximize return on investment. Prior to joining Putnam, Remco developed international expansion strategies for small and mid-size companies in the Netherlands and UK. Remco grew up in the Netherlands and received his bachelors degree in International Management from the Fontys University, Eindhoven, and his Masters degree in International Marketing from the University of Strathclyde in Glasgow, Scotland.

Greg Sullivan is a Medical Director at HEALTHCARE SERVICES GROUP INC, Lab Director at Parkway Medical Center, and Chief Executive Officer at Bridge Therapeutics and is based in Birmingham, Alabama. He attended University of Alabama at Birmingham, ENERNOC INC between 1979 and 1982, and Carraway Methodist Health Systems between 1983 and 1986.